Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AntriaBio Inc (OTCQB:ANTB)

1.60
Delayed Data
As of 10:58am ET
 -0.05 / -3.03%
Today’s Change
0.90
Today|||52-Week Range
2.25
+28.00%
Year-to-Date
SECTOR
Technology Services
INDUSTRY
Internet Software/Services
MARKET CAP
$40.2M

Company Description

AntriaBio, Inc. is a biopharmaceutical company, which focuses on development and sale of novel therapeutic products for the diabetes market. Its products include AB 101 and AB 201. AntriaBio was founded on July 26, 2010 and is headquartered in Louisville, CO.

Contact Information

AntriaBio, Inc.
1450 Infinite Drive
Louisville Colorado 80027
P:(303) 222-2128
Investor Relations:
(650) 549-4175

Employees

Shareholders

Individual stakeholders5.67%
Mutual fund holders--
Other institutional--

Top Executives

Nevan Charles ElamChairman, President & Chief Executive Officer
Sankaram MantripragadaChief Scientific Officer
Brain RobertsVice President-Clinical Development
Hoyoung HuhDirector & Head-Business Development
Morgan Lynn FieldsChief Accounting Officer